‌

US Patent 8895601 Pyrazolyl quinoxaline kinase inhibitors

Patent 8895601 was granted and assigned to Astex Therapeutics Limited on November, 2014 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Current Assignee

‌

Astex Therapeutics Limited

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

88956010

Patent Inventor Names

Elisabeth Thérèse Jeanne Pasquier0

Timothy Pietro Suren Perera0

Valerio Berdini0

Werner Constant Johan Embrechts0

Alexandra Papanikos0

Berthold Wroblowski0

Christopher Charles Frederick Hamlett0

Christopher Norbert Johnson0

...

Date of Patent

November 25, 2014

Patent Application Number

136437410

Date Filed

April 28, 2011

Patent Citations Received

‌

US Patent 11684620 Pharmaceutical compositions comprising N-(3,5-dimethoxyphenyl)-N′-(1-methylethyl)-N-[3-(1-methyl-1H-pyrazol-4-yl)quinoxalin-6-yl]ethane-1,2-diamine

‌

US Patent 11918576 Combination of an FGFR inhibitor and a CMET inhibitor

Patent Primary Examiner

‌

Jeffrey S Lundgren

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8895601 Pyrazolyl quinoxaline kinase inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API